(BHR) Braemar Hotel & Resorts - Ratings and Ratios
Luxury Hotels, Resorts, Real Estate
BHR EPS (Earnings per Share)
BHR Revenue
Description: BHR Braemar Hotel & Resorts
Braemar Hotels & Resorts Inc (NYSE:BHR) is a real estate investment trust (REIT) that specializes in luxury hotels and resorts. As a REIT, the companys primary focus is on generating income through rental properties, in this case, high-end hotels and resorts.
To evaluate the performance of BHR, we can look at key performance indicators (KPIs) such as Revenue per Available Room (RevPAR), Average Daily Rate (ADR), and Occupancy Rate. These metrics provide insights into the companys ability to manage its properties and generate revenue. A strong RevPAR growth, for instance, would indicate that BHR is successfully optimizing its pricing and occupancy strategies.
From a financial perspective, BHRs Market Cap of $193.85M USD suggests a relatively small-cap stock. The companys P/E Forward multiple of 21.28 implies that investors are expecting future earnings growth. However, the negative Return on Equity (RoE) of -1.74% raises concerns about the companys current profitability. Further analysis is needed to understand the drivers behind this negative RoE and whether it is a one-time issue or a persistent problem.
To gain a deeper understanding of BHRs investment potential, it is essential to examine the companys portfolio composition, geographic diversification, and debt profile. A thorough analysis of these factors can help identify potential risks and opportunities, such as exposure to specific markets or reliance on debt financing. By deconstructing these fundamental aspects, we can uncover the underlying drivers of BHRs performance and make more informed investment decisions.
BHR Stock Overview
| Market Cap in USD | 207m |
| Sub-Industry | Hotel & Resort REITs |
| IPO / Inception | 2013-11-06 |
BHR Stock Ratings
| Growth Rating | -23.4% |
| Fundamental | 50.1% |
| Dividend Rating | 55.9% |
| Return 12m vs S&P 500 | -17.6% |
| Analyst Rating | 3.0 of 5 |
BHR Dividends
| Dividend Yield 12m | 9.42% |
| Yield on Cost 5y | 13.66% |
| Annual Growth 5y | -12.68% |
| Payout Consistency | 78.2% |
| Payout Ratio | 37.5% |
BHR Growth Ratios
| Growth Correlation 3m | -37.3% |
| Growth Correlation 12m | -71.7% |
| Growth Correlation 5y | -57.9% |
| CAGR 5y | 8.62% |
| CAGR/Max DD 5y | 0.12 |
| Sharpe Ratio 12m | -1.36 |
| Alpha | -24.73 |
| Beta | 1.450 |
| Volatility | 94.10% |
| Current Volume | 742.6k |
| Average Volume 20d | 187.6k |
| Stop Loss | 2.6 (-5.8%) |
| Signal | 1.42 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-526.0k TTM) > 0 and > 6% of Revenue (6% = 43.0m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 2.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.83% (prev 12.85%; Δ -16.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 44.9m > Net Income -526.0k (YES >=105%, WARN >=100%) |
| Net Debt (1.10b) to EBITDA (136.0m) ratio: 8.06 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.81 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (67.0m) change vs 12m ago 0.77% (target <= -2.0% for YES) |
| Gross Margin 20.87% (prev 15.50%; Δ 5.37pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 33.52% (prev 33.64%; Δ -0.12pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.27 (EBITDA TTM 136.0m / Interest Expense TTM 149.4m) >= 6 (WARN >= 3) |
Altman Z'' -1.13
| (A) -0.01 = (Total Current Assets 117.6m - Total Current Liabilities 145.1m) / Total Assets 2.06b |
| (B) -0.24 = Retained Earnings (Balance) -502.4m / Total Assets 2.06b |
| (C) 0.02 = EBIT TTM 40.3m / Avg Total Assets 2.14b |
| (D) -0.36 = Book Value of Equity -501.9m / Total Liabilities 1.40b |
| Total Rating: -1.13 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.10
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 5.30% = 2.65 |
| 3. FCF Margin 10.96% = 2.74 |
| 4. Debt/Equity 2.10 = 0.63 |
| 5. Debt/Ebitda 9.97 = -2.50 |
| 6. ROIC - WACC -3.15% = -3.94 |
| 7. RoE -0.08% = -0.01 |
| 8. Rev. Trend 12.51% = 0.63 |
| 9. Rev. CAGR 3.90% = 0.49 |
| 10. EPS Trend 6.46% = 0.16 |
| 11. EPS CAGR 12.60% = 1.26 |
What is the price of BHR shares?
Over the past week, the price has changed by +22.67%, over one month by +17.95%, over three months by +19.75% and over the past year by -3.59%.
Is Braemar Hotel & Resorts a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BHR is around 2.62 USD . This means that BHR is currently overvalued and has a potential downside of -5.07%.
Is BHR a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BHR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4 | 44.9% |
| Analysts Target Price | 4 | 44.9% |
| ValueRay Target Price | 2.9 | 3.3% |
Last update: 2025-08-29 04:33
BHR Fundamental Data Overview
CCE Cash And Equivalents = 80.2m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 21.2766
P/S = 0.2893
P/B = 0.8273
Beta = 1.201
Revenue TTM = 716.6m USD
EBIT TTM = 40.3m USD
EBITDA TTM = 136.0m USD
Long Term Debt = 1.21b USD (from longTermDebt, last quarter)
Short Term Debt = 145.1m USD (from totalCurrentLiabilities, last quarter)
Debt = 1.36b USD (Calculated: Short Term 145.1m + Long Term 1.21b)
Net Debt = 1.10b USD (from netDebt column, last quarter)
Enterprise Value = 1.48b USD (206.9m + Debt 1.36b - CCE 80.2m)
Interest Coverage Ratio = 0.27 (Ebit TTM 40.3m / Interest Expense TTM 149.4m)
FCF Yield = 5.30% (FCF TTM 78.6m / Enterprise Value 1.48b)
FCF Margin = 10.96% (FCF TTM 78.6m / Revenue TTM 716.6m)
Net Margin = -0.07% (Net Income TTM -526.0k / Revenue TTM 716.6m)
Gross Margin = 20.87% ((Revenue TTM 716.6m - Cost of Revenue TTM 567.1m) / Revenue TTM)
Tobins Q-Ratio = -2.95 (set to none) (Enterprise Value 1.48b / Book Value Of Equity -501.9m)
Interest Expense / Debt = 5.18% (Interest Expense 70.2m / Debt 1.36b)
Taxrate = 4.09% (from yearly Income Tax Expense: 842.0k / 20.6m)
NOPAT = 38.6m (EBIT 40.3m * (1 - 4.09%))
Current Ratio = 0.81 (Total Current Assets 117.6m / Total Current Liabilities 145.1m)
Debt / Equity = 2.10 (Debt 1.36b / last Quarter total Stockholder Equity 646.7m)
Debt / EBITDA = 9.97 (Net Debt 1.10b / EBITDA 136.0m)
Debt / FCF = 17.26 (Debt 1.36b / FCF TTM 78.6m)
Total Stockholder Equity = 688.1m (last 4 quarters mean)
RoA = -0.03% (Net Income -526.0k, Total Assets 2.06b )
RoE = -0.08% (Net Income TTM -526.0k / Total Stockholder Equity 688.1m)
RoCE = 2.12% (Ebit 40.3m / (Equity 688.1m + L.T.Debt 1.21b))
RoIC = 2.66% (NOPAT 38.6m / Invested Capital 1.45b)
WACC = 5.81% (E(206.9m)/V(1.56b) * Re(11.36%)) + (D(1.36b)/V(1.56b) * Rd(5.18%) * (1-Tc(0.04)))
Shares Correlation 5-Years: 40.0 | Cagr: 1.26%
Discount Rate = 11.36% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 68.98% ; FCFE base≈56.0m ; Y1≈61.8m ; Y5≈79.9m
Fair Price DCF = 12.22 (DCF Value 833.4m / Shares Outstanding 68.2m; 5y FCF grow 11.92% → 3.0% )
Revenue Correlation: 12.51 | Revenue CAGR: 3.90%
Rev Growth-of-Growth: -3.39
EPS Correlation: 6.46 | EPS CAGR: 12.60%
EPS Growth-of-Growth: 93.35
Additional Sources for BHR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle